Variant report

Variant	esv3403714
Chromosome Location	chr11:34706276-34710474
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

No.	Distal block	Cell Line	Cell type	Cell Stage
1	chr11:34666390..34669350-chr11:34705464..34707840,2	K562	blood:
2	chr11:34698695..34700932-chr11:34704220..34706433,3	K562	blood:

Extended variants
information (count: 82 )
Associated
traits (count: 77 )

Variant overlapped rSNPs/rCNVs (count:82 , 50 per page) page: 1 2

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs531750757	chr11:34706279-34706280	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
2	rs187457702	chr11:34706332-34706333	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
3	rs35562812	chr11:34706375-34706376	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
4	rs573648829	chr11:34706503-34706504	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
5	rs542495703	chr11:34706532-34706533	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
6	rs80078425	chr11:34706542-34706543	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
7	rs575650110	chr11:34706546-34706547	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
8	rs147770720	chr11:34706590-34706591	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
9	rs448016	chr11:34706593-34706594	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
10	rs375559704	chr11:34706596-34706597	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
11	rs529113369	chr11:34706637-34706638	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
12	rs192008620	chr11:34706679-34706680	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
13	rs541930437	chr11:34706749-34706750	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
14	rs141075865	chr11:34706810-34706811	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
15	rs530445484	chr11:34706816-34706817	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
16	rs146933690	chr11:34706828-34706829	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
17	rs570328332	chr11:34706874-34706875	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
18	rs539039412	chr11:34706900-34706901	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
19	rs552505722	chr11:34706915-34706916	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
20	rs566081729	chr11:34706921-34706922	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
21	rs137978817	chr11:34706962-34706963	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
22	rs553714158	chr11:34707022-34707023	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
23	rs368324790	chr11:34707026-34707027	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
24	rs184611650	chr11:34707030-34707031	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
25	rs100876	chr11:34707033-34707034	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
26	rs546383507	chr11:34707036-34707037	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
27	rs537412078	chr11:34707046-34707047	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
28	rs532937580	chr11:34707093-34707094	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
29	rs564884948	chr11:34707094-34707095	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
30	rs149065663	chr11:34707109-34707110	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
31	rs541098796	chr11:34707112-34707113	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
32	rs561500135	chr11:34707129-34707130	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
33	rs375868407	chr11:34707179-34707180	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
34	rs189393922	chr11:34707224-34707225	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
35	rs550352443	chr11:34707240-34707241	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
36	rs556446470	chr11:34707252-34707253	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
37	rs551124914	chr11:34707258-34707259	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
38	rs73446857	chr11:34707272-34707273	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
39	rs139321332	chr11:34707292-34707293	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
40	rs145810746	chr11:34707323-34707324	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
41	rs35986920	chr11:34707326-34707327	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
42	rs3930835	chr11:34707327-34707328	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
43	rs532831101	chr11:34707354-34707355	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
44	rs370176842	chr11:34707381-34707382	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
45	rs552336788	chr11:34707439-34707440	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
46	rs566045846	chr11:34707457-34707458	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
47	rs370228350	chr11:34707459-34707460	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
48	rs534843735	chr11:34707478-34707479	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
49	rs548680135	chr11:34707497-34707498	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
50	rs569728658	chr11:34707503-34707504	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a

Variant related diseases (count:77)

Disease	PMID	Source
Breast cancer	17603634	CNVD
Medulloblastoma	21979893	CNVD
Thyroid cancer	19087340	CNVD
Melanoma	18172304	CNVD
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Wilms tumour	21544195	CNVD
Parathyroid adenoma	22454399	CNVD
Chordoma	21602918	CNVD
Breast cancer	21949216	CNVD
Cancer	21637783	CNVD
Non-syndromic sensorineural hearing loss	19222835	CNVD
T-cell acute lymphoblastic leukemia	20065082	CNVD
Ewing''s sarcoma	21437220	CNVD
Glioblastoma multiforme	21080181	CNVD
Endometrial cancer	22040021	CNVD
Astrocytoma	17387387	CNVD
Breast cancer	21264507	CNVD
Beckwith-Wiedemann syndrome	21518781	CNVD
Wilms tumour	21518781	CNVD
Hepatoblastoma	21518781	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Gastrointestinal stromal cancer	17535989	CNVD
Paraganglioma	17535989	CNVD
Pulmonary chondroma	17535989	CNVD
Gastric cancer	17908304	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Multiple myeloma	20724749	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Autism	22495311	CNVD
Prostate cancer	18632612	CNVD
Lung cancer	18438408	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Non-small cell lung cancer	21385341	CNVD
Intellectual disability	22102821	CNVD
Breast cancer	21785460	CNVD
Medulloblastoma	16783165	CNVD
small cell lung cancer	20016488	CNVD
Renal cell carcinoma	18194544	CNVD
Potocki-Shaffer syndrome	19222835	CNVD
WAGR syndrome	19222835	CNVD
Chordoma	18071362	CNVD
Acute lymphoblastic leukemia	22237106	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Chronic lymphocytic leukemia	20421269	CNVD
Glioblastoma multiforme	22286061	CNVD
Breast cancer	21364760	CNVD
Aniridia syndrome	21572526	CNVD
Myelofibrosis	22110671	CNVD
Breast cancer	16272173	CNVD
Retinoblastoma	22278416	CNVD
Denys-drash syndrome	21085971	CNVD
T-cell acute lymphoblastic leukemia	18185524	CNVD
WAGR syndrome	16773131	CNVD
Disorders of sex development	22290220	CNVD
Aniridia syndrome	17204608	CNVD
Mental retardation	17204608	CNVD
WAGR syndrome	19617690	CNVD
genitourinary abnormalities	17204608	CNVD
Breast cancer	16397240	CNVD
Mental retardation	16773131	CNVD
Multiple myeloma	16616336	CNVD
Cancer	17160897	CNVD
Cancer	21183584	CNVD
Malignant peripheral nerve sheath tumor	18522746	CNVD
WAGR syndrome	22470819	CNVD
Neurodevelopmental disorder	22521361	CNVD
Denys-drash syndrome	19566914	CNVD
Familial wilms tumor	19566914	CNVD
Frasier syndrome	19566914	CNVD
Non-small cell lung cancer	21829676	CNVD
WAGR syndrome	20603712	CNVD
Autism	17322880	CNVD
Renal cell carcinoma	18765545	CNVD
Breast cancer	21858162	CNVD
Cancer	20164920	CNVD
Breast cancer	16620391	CNVD

Chromatin state (count:56 , 50 per page) page: 1 2

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr11:34700600-34707200	Weak transcription	ES-WA7 Cell Line	embryonic stem cell
2	chr11:34701800-34706600	Weak transcription	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
3	chr11:34701800-34708200	Enhancers	Foreskin Keratinocyte Primary Cells skin02	Skin
4	chr11:34702400-34708200	Enhancers	HMEC	breast
5	chr11:34702600-34706600	Enhancers	NHEK	skin
6	chr11:34703200-34706600	Enhancers	Hela-S3	cervix
7	chr11:34703200-34706600	Weak transcription	Osteobl	bone
8	chr11:34703200-34706800	Weak transcription	IMR90 fetal lung fibroblasts Cell Line	lung
9	chr11:34703200-34707000	Weak transcription	NHLF	lung
10	chr11:34703400-34706600	Weak transcription	Muscle Satellite Cultured Cells	--
11	chr11:34703400-34706600	Weak transcription	Foreskin Fibroblast Primary Cells skin02	Skin
12	chr11:34703400-34706600	Weak transcription	HSMM	muscle
13	chr11:34703600-34706600	Weak transcription	NHDF-Ad	bronchial
14	chr11:34703600-34707600	Weak transcription	Pancreatic Islets	Pancreatic Islet
15	chr11:34704600-34706800	Weak transcription	HUES6 Cell Line	embryonic stem cell
16	chr11:34705000-34706400	Weak transcription	hESC Derived CD56+ Mesoderm Cultured Cells	ES cell derived
17	chr11:34705000-34707600	Weak transcription	iPS-20b Cell Line	embryonic stem cell
18	chr11:34705200-34706400	Weak transcription	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
19	chr11:34705200-34706400	Weak transcription	Foreskin Keratinocyte Primary Cells skin03	Skin
20	chr11:34705200-34706400	Enhancers	A549	lung
21	chr11:34705200-34706600	Weak transcription	NH-A	brain
22	chr11:34705200-34707000	Weak transcription	HUES64 Cell Line	embryonic stem cell
23	chr11:34705800-34706800	Weak transcription	ES-I3 Cell Line	embryonic stem cell
24	chr11:34705800-34706800	Weak transcription	Foreskin Fibroblast Primary Cells skin01	Skin
25	chr11:34706000-34706400	Weak transcription	Breast variant Human Mammary Epithelial Cells (vHMEC)	Breast
26	chr11:34706400-34707200	Flanking Active TSS	A549	lung
27	chr11:34706400-34708000	Enhancers	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
28	chr11:34706400-34708000	Enhancers	Breast variant Human Mammary Epithelial Cells (vHMEC)	Breast
29	chr11:34706400-34708200	Enhancers	Foreskin Keratinocyte Primary Cells skin03	Skin
30	chr11:34706600-34706800	Enhancers	hESC Derived CD56+ Mesoderm Cultured Cells	ES cell derived
31	chr11:34706600-34707000	Enhancers	Placenta	Placenta
32	chr11:34706600-34707200	Enhancers	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
33	chr11:34706600-34707200	Flanking Active TSS	Muscle Satellite Cultured Cells	--
34	chr11:34706600-34707200	Enhancers	Foreskin Fibroblast Primary Cells skin02	Skin
35	chr11:34706600-34707200	Enhancers	GM12878-XiMat	blood
36	chr11:34706600-34707200	Flanking Active TSS	Hela-S3	cervix
37	chr11:34706600-34707200	Enhancers	HSMM	muscle
38	chr11:34706600-34707200	Enhancers	Osteobl	bone
39	chr11:34706600-34707400	Flanking Active TSS	NHEK	skin
40	chr11:34706600-34707800	Enhancers	NH-A	brain
41	chr11:34706600-34708000	Enhancers	NHDF-Ad	bronchial
42	chr11:34706800-34707200	Enhancers	ES-I3 Cell Line	embryonic stem cell
43	chr11:34706800-34707200	Enhancers	IMR90 fetal lung fibroblasts Cell Line	lung
44	chr11:34706800-34707200	Enhancers	Foreskin Fibroblast Primary Cells skin01	Skin
45	chr11:34706800-34707200	Enhancers	K562	blood
46	chr11:34706800-34707800	Enhancers	HUES6 Cell Line	embryonic stem cell
47	chr11:34707000-34707200	Enhancers	HUES64 Cell Line	embryonic stem cell
48	chr11:34707000-34707200	Enhancers	NHLF	lung
49	chr11:34707200-34707400	Enhancers	ES-WA7 Cell Line	embryonic stem cell
50	chr11:34707200-34707800	Enhancers	Muscle Satellite Cultured Cells	--

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links